These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37986913)

  • 1. Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study.
    Switzer A; Charidimou A; McCarter SJ; Vemuri P; Nguyen A; Przybelski SA; Lesnick TG; Rabinstein AA; Brown RD; Knopman DS; Petersen RC; Jack CR; Reichard RR; Graff-Radford J
    medRxiv; 2023 Nov; ():. PubMed ID: 37986913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study.
    Switzer AR; Charidimou A; McCarter S; Vemuri P; Nguyen AT; Przybelski SA; Lesnick TG; Rabinstein AA; Brown RD; Knopman DS; Petersen RC; Jack CR; Reichard RR; Graff-Radford J
    Neurology; 2024 May; 102(10):e209386. PubMed ID: 38710005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
    Charidimou A; Boulouis G; Frosch MP; Baron JC; Pasi M; Albucher JF; Banerjee G; Barbato C; Bonneville F; Brandner S; Calviere L; Caparros F; Casolla B; Cordonnier C; Delisle MB; Deramecourt V; Dichgans M; Gokcal E; Herms J; Hernandez-Guillamon M; Jäger HR; Jaunmuktane Z; Linn J; Martinez-Ramirez S; Martínez-Sáez E; Mawrin C; Montaner J; Moulin S; Olivot JM; Piazza F; Puy L; Raposo N; Rodrigues MA; Roeber S; Romero JR; Samarasekera N; Schneider JA; Schreiber S; Schreiber F; Schwall C; Smith C; Szalardy L; Varlet P; Viguier A; Wardlaw JM; Warren A; Wollenweber FA; Zedde M; van Buchem MA; Gurol ME; Viswanathan A; Al-Shahi Salman R; Smith EE; Werring DJ; Greenberg SM
    Lancet Neurol; 2022 Aug; 21(8):714-725. PubMed ID: 35841910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Boston Criteria v2.0/v1.5 for Cerebral Amyloid Angiopathy to Predict Recurrent Intracerebral Hemorrhage.
    Fandler-Höfler S; Gattringer T; Enzinger C; Werring DJ
    Stroke; 2023 Jul; 54(7):1901-1905. PubMed ID: 37264913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and Specificity of the Boston Criteria Version 2.0 for the Diagnosis of Cerebral Amyloid Angiopathy in a Community-Based Sample.
    Zanon Zotin MC; Makkinejad N; Schneider JA; Arfanakis K; Charidimou A; Greenberg SM; van Veluw SJ
    Neurology; 2024 Jan; 102(1):e207940. PubMed ID: 38165367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage.
    Schwarz G; Banerjee G; Hostettler IC; Ambler G; Seiffge DJ; Ozkan H; Browning S; Simister R; Wilson D; Cohen H; Yousry T; Al-Shahi Salman R; Lip GYH; Brown MM; Muir KW; Houlden H; Jäger R; Werring DJ
    Int J Stroke; 2023 Jan; 18(1):85-94. PubMed ID: 34994246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Diagnosis of Probable Cerebral Amyloid Angiopathy: Diagnostic Accuracy Meta-Analysis of the Boston Criteria.
    Charidimou A; Boulouis G
    Stroke; 2022 Dec; 53(12):3679-3687. PubMed ID: 36065807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0.
    Charidimou A; Frosch MP; Al-Shahi Salman R; Baron JC; Cordonnier C; Hernandez-Guillamon M; Linn J; Raposo N; Rodrigues M; Romero JR; Schneider JA; Schreiber S; Smith EE; van Buchem MA; Viswanathan A; Wollenweber FA; Werring DJ; Greenberg SM;
    Int J Stroke; 2019 Dec; 14(9):956-971. PubMed ID: 31514686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified Edinburgh CT Criteria for Identification of Lobar Intracerebral Hemorrhage Associated With Cerebral Amyloid Angiopathy.
    Sembill JA; Knott M; Xu M; Roeder SS; Hagen M; Sprügel MI; Mrochen A; Borutta M; Hoelter P; Engelhorn T; Rothhammer V; Macha K; Kuramatsu JB
    Neurology; 2022 May; 98(20):e1997-e2004. PubMed ID: 35314501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of the Boston criteria version 2.0 in Dutch-type hereditary cerebral amyloid angiopathy.
    van der Zwet R; Koemans EA; Voigt S; van Dort R; Rasing I; Kaushik K; van Harten TW; Schipper MR; Terwindt GM; van Osch M; van Walderveen M; van Etten ES; Wermer M
    Int J Stroke; 2024 Oct; 19(8):942-946. PubMed ID: 38444323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified Edinburgh and modified Boston criteria in relation to amyloid PET for lobar intracerebral hemorrhage.
    Michiels L; Dobbels L; Demeestere J; Demaerel P; Van Laere K; Lemmens R
    Neuroimage Clin; 2022; 35():103107. PubMed ID: 35853346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of the Edinburgh CT Criteria for Lobar Intracerebral Hemorrhage Associated with Cerebral Amyloid Angiopathy.
    Grangeon L; Roussel M; Gillibert A; Verdalle-Cazes M; Dolores M; Ozkul-Wermester O; Gilard V; Derrey S; Maltête D; Gerardin E; Joly LM; Wallon D; Magne N
    Clin Neuroradiol; 2023 Jun; 33(2):455-465. PubMed ID: 36598532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral amyloid angiopathy - The modified Boston criteria in clinical practice.
    Caetano A; Ladeira F; Barbosa R; Calado S; Viana-Baptista M
    J Neurol Sci; 2018 Jan; 384():55-57. PubMed ID: 29249378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and neuroimaging precursors in cerebral amyloid angiopathy: impact of the Boston criteria version 2.0.
    Weidauer S; Tafreshi M; Förch C; Hattingen E; Arendt CT; Friedauer L
    Eur J Neurol; 2024 Oct; 31(10):e16425. PubMed ID: 39105407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?
    Charidimou A; Jaunmuktane Z; Baron JC; Burnell M; Varlet P; Peeters A; Xuereb J; Jäger R; Brandner S; Werring DJ
    Neurology; 2014 Jan; 82(1):57-62. PubMed ID: 24285616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Intracerebral Hemorrhage and Mortality After Convexity Subarachnoid Hemorrhage in Cerebral Amyloid Angiopathy.
    Calviere L; Viguier A; Patsoura S; Rousseau V; Albucher JF; Planton M; Pariente J; Cognard C; Olivot JM; Bonneville F; Raposo N
    Stroke; 2019 Sep; 50(9):2562-2564. PubMed ID: 31337297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral amyloid angiopathy-related acute lobar intra-cerebral hemorrhage: diagnostic value of plain CT.
    Baron JC; Boulouis G; Benzakoun J; Schwall C; Oppenheim C; Turc G; Varlet P
    J Neurol; 2022 Apr; 269(4):2126-2132. PubMed ID: 34510255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for Late Post-Intracerebral Hemorrhage Dementia in Patients with Probable Cerebral Amyloid Angiopathy.
    Xiong L; Charidimou A; Pasi M; Boulouis G; Pongpitakmetha T; Schirmer MD; Singh S; Benson E; Gurol EM; Rosand J; Greenberg SM; Biffi A; Viswanathan A
    J Alzheimers Dis; 2019; 71(2):435-442. PubMed ID: 31403947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Anticoagulant Use With Hemorrhage Location and Etiology in Incident Spontaneous Intracerebral Hemorrhage.
    Wilson M; Incontri D; Vu S; Marchina S; Wang JY; Andreev A; Heistand E; Carvalho F; Selim M; Lioutas VA
    Stroke; 2024 Nov; 55(11):2677-2684. PubMed ID: 39355909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral amyloid angiopathy: Neuropathological diagnosis, link to Alzheimer's disease and impact on clinics.
    Thal DR; Gawor K
    Clin Neuropathol; 2023; 42(5):176-189. PubMed ID: 37489069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.